Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. tumor models for pancreatic cancer
Show results for
Articles

Refine by
Date

  • Older

Tumor Models For Pancreatic Cancer Articles & Analysis

28 articles found

Alfa Cytology Launches Innovative Bladder Cancer Therapeutic Antibody Development Services

Alfa Cytology Launches Innovative Bladder Cancer Therapeutic Antibody Development Services

Alfa Cytology has unveiled new services focused on therapeutic antibody development for bladder cancer research.Alfa Cytology, a prominent cancer research services supplier based in New York, proudly announces the launch of its comprehensive services for bladder cancer therapeutic antibody development. This initiative represents a critical advancement in pursuing effective bladder cancer ...

ByAlfa Cytology


Alfa Cytology Announces Pancreatic Cancer Vaccine Development Services to Explore Reliable Immunotherapy in Preclinical Trails

Alfa Cytology Announces Pancreatic Cancer Vaccine Development Services to Explore Reliable Immunotherapy in Preclinical Trails

Alfa Cytology has announced pancreatic cancer vaccine development services to improve the efficacy and safety of related vaccines. ...

ByAlfa Cytology


Alfa Cytology Introduces Bespoke Tumor Models for Pancreatic Cancer Research

Alfa Cytology Introduces Bespoke Tumor Models for Pancreatic Cancer Research

Alfa Cytology has announced tumor models customization service for pancreatic cancer research. Alfa Cytology, a biotech company specializing in cancer research, has recently unveiled the service on pancreatic cancer tumor model customization to ...

ByAlfa Cytology


Cytokine Profiling in Oncology: The Power of Luminex Technology   

Cytokine Profiling in Oncology: The Power of Luminex Technology  

Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. Cytokines play a critical role in this interplay, mediating the communication between different cells of the immune system and modulating immune responses. As such, cytokine profiling is becoming increasingly important in the study of cancer and is being used to support research, ...

ByCreative Proteomics


The Role of Cytokine Profiling in Oncology Research

The Role of Cytokine Profiling in Oncology Research

Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. Cytokines play a critical role in this interplay, mediating the communication between different cells of the immune system and modulating immune responses. As such, cytokine profiling is becoming increasingly important in the study of cancer and is being used to support research, ...

ByCreative Proteomics


Exploring the Potential of Bioconjugation: Deep Dive into SN38-BSA as a Game-Changer in Cancer Treatment

Exploring the Potential of Bioconjugation: Deep Dive into SN38-BSA as a Game-Changer in Cancer Treatment

SN38-BSA is a bioconjugate product that is effectively revolutionizing the field of drug delivery. This article focuses on understanding its makeup and how bioconjugation is instrumental in its function and efficacy. To begin with, SN38-BSA is composed of SN38, a potent anti-cancer drug, and BSA or Bovine Serum Albumin. SN38 is the active metabolite of the prodrug irinotecan, commonly used in ...

ByBOC Sciences


Unveiling the Role of CD73: A Key Player in Immune Regulation and Beyon

Unveiling the Role of CD73: A Key Player in Immune Regulation and Beyon

Additionally, adenosine binds to the A2B receptor expressed by cancer cells themselves, facilitating tumor cell survival and proliferation. ...

ByBeta Lifescience


What are the Possibilities for ADCs Targeting Trop2?

What are the Possibilities for ADCs Targeting Trop2?

It is currently undergoing multiple clinical trials and is used alone or in combination to treat metastatic triple-negative breast cancer (first-line or adjuvant treatment), metastatic breast cancer, non-small cell lung cancer, metastatic Urothelial carcinoma, metastatic castration-resistant prostate cancer, and other solid ...

ByBOC Sciences


An Emerging Aim: ADC Target Protein - Nectin-4

An Emerging Aim: ADC Target Protein - Nectin-4

The biologics license application (BLA) has been accepted for Enfortumab Vedotin for the treatment of locally advanced or metastatic urothelial carcinoma in patients who have previously received PD-1/PD-L1 inhibitors and platinum-containing chemotherapy. Enfortumab Vedotin is the first domestically submitted targeted antibody-drug conjugate that specifically targets Nectin-4. Enfortumab ...

ByBeta Lifescience


Autoimmune Diseases Targets

Autoimmune Diseases Targets

Thymic Stromal Lymphopoietin (TSLP) is a multifunctional cytokine that acts on various cell types, including dendritic cells, T cells, B cells, neutrophils, mast cells, eosinophils, and innate lymphoid cells, affecting their maturation, survival, and recruitment. It is well-known for its role in promoting type 2 immune responses, such as allergic diseases. In 2021, a monoclonal antibody targeting ...

ByBeta Lifescience


ADC Drugs For Breast Cancer Treatment

ADC Drugs For Breast Cancer Treatment

Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer ...

ByBiopharma PEG Scientific Inc


Cancer Target: Mesothelin

Cancer Target: Mesothelin

Mesothelin is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein. Its biological function has not yet been clarified, but due to its limited distribution in normal tissues and high expression in some tumor tissues, it is expected to be used in tumor-specific treatment. In existing studies of human epidermoid carcinoma cell lines expressing mesothelin, biodistribution analysis ...

ByCreative Diagnostics


Mesothelin: A New Target for Cancer Therapy

Mesothelin: A New Target for Cancer Therapy

Structure and function of mesothelin The MSLN gene is located in chromosome 16p13. It contains 17 exons, with a cDNA length of about 2138bp, has a 1884-bp open reading frame, and encodes the precursor protein of 628 amino acids (69 kDa). This precursor protein can be hydrolyzed by furin protease into two parts: mesothelin in the size of 40 kDa fragments and 31 kDa secreted fragments called ...

ByBOC Sciences


Bilateral Insufficiency Fractures in an Oncology Patient Treatment with the CurvaFix IM System - Case Study

Bilateral Insufficiency Fractures in an Oncology Patient Treatment with the CurvaFix IM System - Case Study

CASE PRESENTATION A 70-year-old female recently diagnosed with metastatic pancreatic cancer presented with acute new onset of lower back pain. The patient was taking chemotherapy, participating in a drug therapy trial, and had received radiation therapy. There was no history of acute trauma to the pelvic or acetabular region. Magnetic resonance imaging revealed bilateral fragility fractures, with ...

ByCurvaFix, Inc.


Novel Mechanism of Glycosylation Regulating Pancreatic Cancer Reveled

Novel Mechanism of Glycosylation Regulating Pancreatic Cancer Reveled

Pancreatic cancer is a highly malignant digestive system tumor, and the five-year survival rate of patients after diagnosis is only about 10%. Changes in metabolism are one of the important features of tumor cells. Tumor cells undergo metabolic reprogramming to generate the substances, energy, and redox forces required for their rapid proliferation. The proliferation of pancreatic ductal ...

ByCD BioGlyco.


CAR-T Cell Anti-Cancer Therapy Ushered in A Revolutionary Breakthrough!

CAR-T Cell Anti-Cancer Therapy Ushered in A Revolutionary Breakthrough!

They designed for the first time a chimeric receptor fused with orthogonal IL-2 receptor (oIL-2R) and IL-9 receptor (IL-9R) that activates adoptive T cells without the need for prior chemoradiotherapy for myeloablative treatment and confers a dual phenotype of their stem-like memory T cells and effector T cells to effectively exert anti-tumor function. More importantly, this ...

ByCreative BioMart


Inflammation in Periodontal Disease a Red Flag for Cancer

Inflammation in Periodontal Disease a Red Flag for Cancer

By not taking care of your teeth there is more on the line than tooth decay and periodontal disease – although that’s bad enough. Practicing good oral hygiene may be lifesaving according to a number of research studies.Studies show a connection between Gum disease and a 63% HIgher Pancreatic Cancer in Men The link between several systemic illnesses including diabetes, heart disease, ...

ByDental Air Force Labs


Dental Problems Linked To Heart Disease and Diabetes

Dental Problems Linked To Heart Disease and Diabetes

Dental Problems Linked To Heart Disease and Diabetes Over the last ten years there has been a growing body of evidence linking periodontal disease and systemic diseases. Every day new research is making the link stronger. Periodontal infection is the advanced stages of gum disease that causes bone loss. The bone loss is irreversible. Gingivitis is the early stage of gum disease and with early ...

ByDental Air Force Labs


Methylation Markers of Pancreatic Cancer categorization and prognosis evaluation

Methylation Markers of Pancreatic Cancer categorization and prognosis evaluation

Background Pancreatic cancer is one of the highest mortality rate cancers worldwide with 5-year relative survival of 10.8%. Lack of screening methods for early-stage detection as well as proper patient sub-characterization, make it a fatal cancer due to poor diagnoses and insufficient treatment. Methylation flags are kept on tumorigenesis, akin to the tissue-specific traces that are acquired and ...

ByUniversal Diagnostics SL


LAG-3 antibody drug R&D boom   

LAG-3 antibody drug R&D boom  

On March 19, Bristol-Myers Squibb (BMS) announced that its dual immunotherapy combination Opdualag had received accelerated marketing approval from the FDA. Opdualag therapy is a fixed-dose combination of Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) for the treatment of adult and pediatric patients 12 years of age and older with unresectable or metastatic melanoma, making LAG-3 the third ...

ByCreative Biolabs

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT